Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type A vs Local Anesthetic for Chronic Neuroma Pain After Combat-Related Amputation
NCT07626983Completed
- Sponsor
- Ukrainian Society of Regional Anesthesia and Pain Therapy
- Start
- May 2026
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial of botulinum toxin type A in Neuroma (2 arms), sponsored by Ukrainian Society of Regional Anesthesia and Pain Therapy. Primary endpoint: Change in neuroma pain intensity at 12 weeks. Started May 2026; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Neuroma
Beyond the preview
Go deeper on NCT07626983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07626983.